Skip to main content
SpringerLink
Log in

Advances in Clinical Research and Management of Diffuse Peritoneal Mesothelioma

  • Chapter
Book cover Advances in Peritoneal Surface Oncology

Part of the book series: Resent Results in Cancer Research ((RECENTCANCER,volume 169))

  • 515 Accesses

Abstract

Diffuse malignant mesothelioma is a tumor arising from the serosal surfaces of the pleura, peritoneum, pericardium, or tunica vaginalis testis. Although the tumor is exceedingly uncommon, there is a substantial interest in this disease, as either biological or occupational and medical-legal issues are concerned: asbestos is the principal carcinogen associated with malignant mesothelioma, and up to 8 million living persons in the USA have been occupationally exposed to asbestos over the last five decades (Robinson and Lake 2005).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Altieri DC (2003a) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46–54

    Article  CAS  PubMed  Google Scholar 

  • Altieri DC (2003b) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581–8589

    Article  CAS  PubMed  Google Scholar 

  • Antman KH, Blum RH, Greenberger JS et al. (1980) Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 68:356–362

    Article  CAS  PubMed  Google Scholar 

  • Antman KH, Corson JM, Li FP et al. (1983) Malignant mesothelioma following radiation exposure. J Clin Oncol 1:695–700

    CAS  PubMed  Google Scholar 

  • Arancia G, Crateri Trovalusci P, Mariutti G et al. (1989) Ultrastructural changes induced by hyperthermia in Chinese hamster V79 fibroblasts. Int J Hyperthermia 5:341–350

    Article  CAS  PubMed  Google Scholar 

  • Archer VE, Rom WN (1983)Trends in mortality of diffuse malignant mesothelioma of pleura. Lancet 2:112–113

    Article  CAS  PubMed  Google Scholar 

  • Baratti D et al. (2007) Circulating CA125 in patients with peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 14:500–508

    Article  PubMed  Google Scholar 

  • Baris YI, Sahin AA, Ozesmi M et al. (1978) An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia. Thorax 33:181–192

    Article  CAS  PubMed  Google Scholar 

  • Barlogie B, Corry PM, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Res 40:1165–1168

    CAS  PubMed  Google Scholar 

  • Berghmans T et al. (2002) Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with metaanalysis. Lung Cancer 38:112–121

    Article  Google Scholar 

  • Blackburn EH (2001) Structure and function of telomeres. Nature 350:569–573

    Article  Google Scholar 

  • Brigand C, Monneuse O, Mohamed F et al. (2006) Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 13:405–412

    Article  CAS  PubMed  Google Scholar 

  • Bryan TM, Englezou A, Dalla-Pozza L et al. (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271–1274

    Article  CAS  PubMed  Google Scholar 

  • Cain J, Nori D, Huvos A et al. (1983) The role of radioactive colloids in malignant peritoneal mesotheliomas. Gynecol Oncol 16:263–274

    Article  CAS  PubMed  Google Scholar 

  • Calderwood SK, Hahn GM (1983) Thermal sensitivity and resistance of insulin-receptor binding. Biochim Biophys Acta 756:1–8

    CAS  PubMed  Google Scholar 

  • Carmignani CP, Sugarbaker TA, Bromley CM et al. (2003) Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 22:465–472

    Article  PubMed  Google Scholar 

  • Chan PS, Balfour TW, Bourke JB et al. (1975) Peritoneal nesothelioma. Br J Surg 62:576–580

    Article  CAS  PubMed  Google Scholar 

  • Churg A, Cagle PT, Roggli VL (2006) Tumors of the serosal membranes. In: Atlas of tumor pathology, IV series. AFIP, Washington DC

    Google Scholar 

  • Cong YS et al. (2002) Human telomerase and its regulation. Microbiol Mol Biol Rev 66:407–425

    Article  CAS  PubMed  Google Scholar 

  • Dedrick RL, Flessner MF (1997) Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst 89:480–487

    Article  CAS  PubMed  Google Scholar 

  • Deraco M, Santoro N, Carraro O et al. (1999) Peritoneal carcinomatosis: feature of dissemination. A review. Tumori 85:1–5

    CAS  Google Scholar 

  • Deraco M, Rossi CR, Pennacchioli E et al. (2001) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori 87:120–126

    CAS  PubMed  Google Scholar 

  • Deraco M, Raspagliesi F, Kusamura S et al. (2003a) Management of peritoneal surface component of ovarian cancer. Surg Oncol Clin N Am 12:561–583

    Article  PubMed  Google Scholar 

  • Deraco M, Casali P, Inglese MG et al. (2003b) Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 83:147–153

    Article  PubMed  Google Scholar 

  • Deraco M, Baratti D, Inglese MG et al. (2004) Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11:393–398

    Article  PubMed  Google Scholar 

  • DuBose DA, Hinkle JR, Morehouse DH et al. (1998) Model for environmental heat damage of the blood vessel barrier. Wilderness Environ Med 9:130–136

    CAS  PubMed  Google Scholar 

  • Dunham MA, Neumann AA, Fasching CL et al. (2000) Telomere maintenance by recombination in human cells. Nat Genet 26:447–450

    Article  CAS  PubMed  Google Scholar 

  • Eggermont AM et al. (1987) Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. Surgery 102:71–78

    CAS  PubMed  Google Scholar 

  • Eisenkop SM, Friedman RL, Wang HJ (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69:103–108

    Article  CAS  PubMed  Google Scholar 

  • Elias D, Blot F, El Otmany A et al. (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71–76

    Article  CAS  PubMed  Google Scholar 

  • Eltabbakh GH, Piver MS, Hempling RE et al. (1999) Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 70:6–12

    Article  CAS  PubMed  Google Scholar 

  • Engelhardt R (1987) Hyperthermia and drugs. Rec Res Cancer Res 104:136–203

    CAS  Google Scholar 

  • Feldman AL, Libutti SK, Pingpank JF et al. (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21:4560–4567

    Article  CAS  PubMed  Google Scholar 

  • Fujimoto S, Takahashi M, Mutou T et al. (1997) Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79:884–891

    Article  CAS  PubMed  Google Scholar 

  • Gazdar AF, Carbone M (2003) Molecular pathogenesis of mesothelioma and its relationship to Simian virus 40. Clin Lung Cancer 5:177–181

    Article  PubMed  Google Scholar 

  • Gilly FN, Carry PY Sayag AC et al. (1994) Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41:124–129

    CAS  PubMed  Google Scholar 

  • Glehen O, Mithieux F, Osinsky D et al. (2003) Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 21:799–806

    Article  CAS  PubMed  Google Scholar 

  • Gordon GJ, Appasani K, Parcells JP et al. (2002) Inhibition of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis 23:1017–1024

    Article  CAS  PubMed  Google Scholar 

  • Hahn WC, Counter CM, Lundberg AS et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400:464–468

    Article  CAS  PubMed  Google Scholar 

  • Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3–13

    Article  PubMed  Google Scholar 

  • Hassan R, Alexander R (2005) Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis ad pericardium. Hemat Oncol Clin N Am 19:1067–1087

    Article  Google Scholar 

  • Hassan R, Alexander R, Antman K et al. (2006) Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol (in press)

    Google Scholar 

  • Henson JD, Neumann AA, Yeager TR et al. (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene 21:598–610

    Article  CAS  PubMed  Google Scholar 

  • Henson JD, Hannay JA, McCarthy SW et al. (2005) A robust assay for alternative lengthening of telomeres in tumours shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11:217–225

    CAS  PubMed  Google Scholar 

  • Hettinga JV, Lemstra W, Meijer C et al. (1997) Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and-resistant tumor cells. Br J Cancer 75:1735–1743

    CAS  PubMed  Google Scholar 

  • Iwamoto A (1989) [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer]. Gan To Kagaku Ryoho 16:2748–2751

    CAS  PubMed  Google Scholar 

  • Janne PA, Wozniak AJ, Belani CP et al. (2006) Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer 7:40–46

    Article  Google Scholar 

  • Jacquet P, Sugarbaker PH (1996)Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15:49–58

    Google Scholar 

  • Kannerstein M, Churg J (1977) Peritoneal mesothelioma. Hum Pathol 8:83–94

    Article  CAS  PubMed  Google Scholar 

  • Krug LM (2005) An overview of chemotherapy for mesothelioma. Hemat Oncol Clin N Am 19:117–136

    Google Scholar 

  • Kumaki F, Kawai T, Churg A et al. (2002) Expression of telomerase reverse transcriptase in malignant mesotheliomas. Am J Surg Pathol 26:365–370

    Article  PubMed  Google Scholar 

  • Kusamura S, Younan R, Baratti D et al. (2006) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: analysis of morbidity and mortality in 209 cases treated with closed abdomen technique. Cancer 106:1144–1153

    Article  PubMed  Google Scholar 

  • Kuzuya T, Yamauchi M, Ito A et al. (1994) Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy. J Pharm Pharmacol 46:685–689

    CAS  PubMed  Google Scholar 

  • Langer JC et al. (1993) Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with multimodality approach. Cancer Chemother Pharmacol 32:204–208

    Article  CAS  PubMed  Google Scholar 

  • Lederman GS, Recht A, Herman T et al. (1987) Longterm survival in peritoneal mesothelioma: the role of radiotherapy and combined modality treatment. Cancer 59:1882–1886

    Article  CAS  PubMed  Google Scholar 

  • Leigh J, Robinson BWS (2002) The history of mesothelioma in Australia. In: Robinson BWS, Chahinian PA (eds) Mesothelioma. Martin Dunitz, London, pp 55–210

    Google Scholar 

  • Leunig M, Goetz AE, Dellian M et al. (1992) Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. Cancer Res 52:487–490

    CAS  PubMed  Google Scholar 

  • Loggie BW, Fleming RA, Mc Quellon RP et al. (2001) Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 67:999–1003

    CAS  PubMed  Google Scholar 

  • Markman M, Kelsen D (1992) Efficacy of cisplatin-based intra-peritoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 118:547–550

    Article  CAS  PubMed  Google Scholar 

  • Maurer F, Egloff B (1975) Malignant peritoneal mesothelioma after cholangiography with thorotrast. Cancer 36:1381–1385

    Article  CAS  PubMed  Google Scholar 

  • McDonald JC (1985) Health implications of environmental exposure to asbestos. Environ Health Perspect 62:318–329

    Article  Google Scholar 

  • McDonald JC (2000) Asbestos. In: McDonald JC (ed) Epidemiology of work related disease. BMJ Books, London, pp 85–108

    Chapter  Google Scholar 

  • Moertel CG (1972) Peritoneal mesothelioma. Gastroenterology 63:346–350

    CAS  PubMed  Google Scholar 

  • Murajama T (2004) Emerging health effects of asbestos in Asia. In: Proceedings of the global asbestos congress, Tokyo, November 19–21, 2004: 17, abstract

    Google Scholar 

  • Nonaka D, Kusamura S, Baratti D et al. (2005) Diffuse malignant mesothelioma of the peritoneum. Cancer 104:2181–2188

    Article  PubMed  Google Scholar 

  • Oken MM, Creech RH, Tormey DC et al. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  CAS  PubMed  Google Scholar 

  • Ordonez NG (1998) Value of cytokeratin 5/6 immunostaining in distinguish epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 22:1215–1221

    Article  CAS  PubMed  Google Scholar 

  • Ozols RF, Young RC (1987) Ovarian cancer. Curr Probl Cancer 11:57–122

    Article  CAS  PubMed  Google Scholar 

  • Park BJ, Alexander HR, Libutti SK et al. (1999) Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion(CHPP). Ann Surg Oncol 6:582–590

    Article  CAS  PubMed  Google Scholar 

  • Pass HI, Lott D, Lonardo F et al. (2005) Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 353:1564–1573

    Article  CAS  PubMed  Google Scholar 

  • Peto J, Hodgson JT, Matthews FE et al. (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345:535–539

    Article  CAS  PubMed  Google Scholar 

  • Peto J, Decarli A, La Vecchia C et al. (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672

    Article  CAS  PubMed  Google Scholar 

  • Pisick E, Salgia R (2005) Molecular biology of malignant mesothelioma: a review. Hemat Oncol Clin N Am 19

    Google Scholar 

  • Price B (1997) Analysis of current trends in the United States mesothelioma incidence. Am J Epidemiol 45:211–218

    Google Scholar 

  • Robinson BWS, Creaney J, Lake R et al. (2003) Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362:1612–1616

    Article  CAS  PubMed  Google Scholar 

  • Robinson BWS, Lake RA (2005) Advanced in malignant mesothelioma. N Engl J Med 353:1591–603

    Article  CAS  PubMed  Google Scholar 

  • Robinson BWS, Musk AW, Lake RA et al. (2005) Malignant mesothelioma. Lancet 366:397–408

    Article  CAS  PubMed  Google Scholar 

  • Roushdy-Hammady I, Siegel J, Emri S et al. (2001) Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357:444–445

    Article  CAS  PubMed  Google Scholar 

  • van Ruth S, Verwaal VJ, Hart AA et al. (2003) Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy. Anticancer Res 23:1501–1508

    PubMed  Google Scholar 

  • Sadeghi B, Arvieux C, Glehen O et al. (2000) Peritoneal carcinomatosis from non-gynaecologic malignancies. Results of the EVOCAPE1 multicentric prospective study. Cancer 88:358–363

    Article  CAS  PubMed  Google Scholar 

  • Sebbag G, Yan H, Shmookler BM et al. (2000) Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87:1587–1593

    Article  CAS  PubMed  Google Scholar 

  • Shen P, Levine EA, Hall J et al. (2003) Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138:26–33

    Article  CAS  PubMed  Google Scholar 

  • Spirtas R, Heineman EF, Bernstein L et al. (1994) Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 51:804–811

    Article  CAS  PubMed  Google Scholar 

  • Stewart JH, Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 12:765–777

    Article  PubMed  Google Scholar 

  • Sugarbaker PH (1994) Pseudomyxoma peritonei: a cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 219:109–111

    Article  CAS  PubMed  Google Scholar 

  • Sugarbaker PH (1999a) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–731

    Article  CAS  PubMed  Google Scholar 

  • Sugarbaker PH (1999b) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43[Suppl]:S15–S25

    Article  PubMed  Google Scholar 

  • Sugarbaker PH (2003) Peritonectomy procedures. Surg Oncol Clin North Am 12:703–727

    Article  Google Scholar 

  • Sugarbaker PH, Graves T, DeBruijn EA et al. (1990) Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 50:5790–5794

    CAS  PubMed  Google Scholar 

  • Sugarbaker PH, Welch LS, Mohamed F et al. (2003) A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin North Am 12:605–621

    Article  Google Scholar 

  • Sugarbaker PH et al. (2006) Comprehensive management of diffuse malignant peritoneal mesothelioma. EJSO (in press)

    Google Scholar 

  • Takayhashi H (2004) Emerging health effects of asbestos in Asia. In: Proceedings of the global asbestos congress, Tokyo, November 19–21, 2004: 2, abstract

    Google Scholar 

  • Tentes AAK, Trispsiannis G, Markakidis SK et al. (2003) Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29:69–73

    Article  PubMed  Google Scholar 

  • Vaupel PW (1997) The influence of tumor blood flow and micro-environmental factors on the efficacy of radiation, drugs and localized hyperthermia. Klin Paediatr 209:243–249

    Article  CAS  Google Scholar 

  • Vlasveld LT, Gallee MP, Rodenhuis S et al. (1991) Intraperitoneal chemotherapy for malignant peritoneal mesothelioma. Eur J Cancer 27:732–734

    Article  CAS  PubMed  Google Scholar 

  • Vogelzang NJ, Rusthoven JJ, Symanowski J et al. (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644

    Article  CAS  PubMed  Google Scholar 

  • Wagner JC, Sleggs CA, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17:260–271

    CAS  PubMed  Google Scholar 

  • Whitaker D (2000) The cytology of malignant mesothelioma. Cytopathology 11:139

    Article  CAS  PubMed  Google Scholar 

  • Witkamp AJ, de Bree E, Kaag MM et al. (2001) Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979–984

    Article  CAS  PubMed  Google Scholar 

  • Xia C, Xu Z, Yuan X et al. (2002) Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther 1:687–694

    CAS  PubMed  Google Scholar 

  • Xu M, Myerson RJ, Straube WL et al. (2002) Radiosensitization of heat resistant human tumour cells by 1 hour at 41.1 degrees C and its effect on DNA repair. Int J Hyperthermia 18:385–403

    Article  CAS  PubMed  Google Scholar 

  • Yan TD, Haveric N, Carmignani CP et al. (2005a) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103:839–849

    Article  PubMed  Google Scholar 

  • Yan TD, Haveric N, Carmignani CP et al. (2005b) Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 91:394–400

    PubMed  Google Scholar 

  • Younan R, Kusamura S, Baratti D et al. (2005) Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 12:910–918

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, National Cancer Institute, Via Venezian 1, 20133, Milan, Italy

    Marcello Deraco MD, Dario Baratti MD & Shigeki Kusamura MD, PhD

  2. Department of Experimental Oncology, National Cancer Institute, Via Venezian 1, 20133, Milan, Italy

    Nadia Zaffaroni PhD

  3. Department of Pathology, National Cancer Institute, Via Venezian 1, 20133, Milan, Italy

    Antonello Domenico Cabras MD

Authors
  1. Marcello Deraco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dario Baratti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadia Zaffaroni PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonello Domenico Cabras MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shigeki Kusamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgical Oncology, Centro Oncológico MD Anderson International España, Calle Gómez Hemans 2, 28033, Madrid, Spain

    Santiago González-Moreno MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Deraco, M., Baratti, D., Zaffaroni, N., Cabras, A.D., Kusamura, S. (2007). Advances in Clinical Research and Management of Diffuse Peritoneal Mesothelioma. In: González-Moreno, S. (eds) Advances in Peritoneal Surface Oncology. Resent Results in Cancer Research, vol 169. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-30760-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-30760-0_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-30759-4

  • Online ISBN: 978-3-540-30760-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation